Litcius/Paper detail

Parallel profiling of antigenicity alteration and immune escape of SARS-CoV-2 Omicron and other variants

Cong Sun, Yinfeng Kang, Yuan-Tao Liu, Xiang‐Wei Kong, Hui-Qin Xu, Dan Xiong, Chu Xie, Yihao Liu, Sui Peng, Guo‐Kai Feng, Zheng Liu, Mu‐Sheng Zeng

2022Signal Transduction and Targeted Therapy39 citationsDOIOpen Access PDF

Abstract

SARS-CoV-2 variants have evolved a variety of critical mutations, leading to antigenicity changes and immune escape. The recent emerging SARS-CoV-2 Omicron variant attracted global attention due to its significant resistance to current antibody therapies and vaccines. Here, we profiled the mutations of Omicron and other various circulating SARS-CoV-2 variants in parallel by computational interface analysis and in vitro experimental assays. We identified critical mutations that lead to antigenicity changes and diminished neutralization efficiency of a panel of 14 antibodies due to diverse molecular mechanisms influencing the antigen-antibody interaction. Our study identified that Omicron exhibited extraordinary potency in immune escape compared to the other variants of concern, and explores the application of computational interface analysis in SARS-CoV-2 mutation surveillance and demonstrates its potential for the early identification of concerning variants, providing preliminary guidance for neutralizing antibody therapy.

Topics & Concepts

AntigenicityImmune escapeAntibodyImmune systemVirologyAntigenNeutralizationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)BiologyNeutralizing antibodyPhenotypeCoronavirus disease 2019 (COVID-19)Computational biologyImmunologyGeneticsMedicineInfectious disease (medical specialty)GeneDiseasePathologySARS-CoV-2 and COVID-19 ResearchMonoclonal and Polyclonal Antibodies ResearchCAR-T cell therapy research
Parallel profiling of antigenicity alteration and immune escape of SARS-CoV-2 Omicron and other variants | Litcius